These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2896479)

  • 1. [Use of new inotropic agents in the treatment of acute cardiac failure].
    Dhainaut JF
    Ann Fr Anesth Reanim; 1988; 7(2):97-104. PubMed ID: 2896479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New positive inotropic drugs].
    Lehot JJ
    Ann Fr Anesth Reanim; 1991; 10(1):62-9. PubMed ID: 1672585
    [No Abstract]   [Full Text] [Related]  

  • 4. Some new positive inotropic agents.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH; Keren G; Reis D; Sonnenblick EH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General overview and update of positive inotropic therapy.
    Leier CV
    Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new inotropic phosphodiesterase inhibitors.
    el Allaf D; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New positive inotropic drugs for the treatment of congestive heart failure.
    Sonnenblick EH; Mancini DM; LeJemtel TH
    Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents.
    Tisdale JE; Patel R; Webb CR; Borzak S; Zarowitz BJ
    Prog Cardiovasc Dis; 1995; 38(2):167-80. PubMed ID: 7568905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inotropic drugs].
    Presbitero P; Chiotti D
    Cardiologia; 1988 Aug; 33(8):747-53. PubMed ID: 2904301
    [No Abstract]   [Full Text] [Related]  

  • 16. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F
    Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of inotropes in the critical care setting.
    Löllgen H; Drexler H
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT
    Prog Cardiovasc Nurs; 1987; 2(3):100-4. PubMed ID: 2959954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.